Jagsonpal Pharmaceuticals Ltd Q3 FY2023 PAT drops QoQ to Rs. 7.78 crores

Jagsonpal Pharmaceuticals Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 61.8807 crores during the period ended December 31, 2022 as compared to Rs. 61.6469 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 7.7849 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 10.4123 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 2.97 for the period ended December 31, 2022 as compared to Rs. 3.97 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹61.8807 crs	₹61.6469 crs	0.38%
Net Profit	₹7.7849 crs	₹10.4123 crs	-25.23%
EPS	₹2.97	₹3.97	-25.19%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.61.8807 crores during the period ended December 31, 2022 as compared to Rs.55.8635 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.7.7849 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.5.2911 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.2.97 for the period ended December 31, 2022 as compared to Rs.2.02 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹61.8807 crs	₹55.8635 crs	10.77%
Net Profit	₹7.7849 crs	₹5.2911 crs	47.13%
EPS	₹2.97	₹2.02	47.03%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.184.1818 crores during the 9 Months period ended December 31, 2022 as compared to Rs.169.4180 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.21.1188 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.18.4354 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.8.06 for the 9 Months period ended December 31, 2022 as compared to Rs.7.04 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹184.1818 crs	₹169.4180 crs	8.71%
Net Profit	₹21.1188 crs	₹18.4354 crs	14.56%
EPS	₹8.06	₹7.04	14.49%

Shares of Jagsonpal Pharmaceuticals Limited was last trading in BSE at Rs. 330.00 as compared to the previous close of Rs. 327.00. The total number of shares traded during the day was 745 in over 106 trades.

The stock hit an intraday high of Rs. 333.95 and intraday low of 328.40. The net turnover during the day was Rs. 246764.00.

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals Q3FY23 9MFY23 ResultUpdate